Literature DB >> 23317074

Evaluation and treatment of endometriosis.

Sarina Schrager1, Julianne Falleroni, Jennifer Edgoose.   

Abstract

Endometriosis, which affects up to 10 percent of reproductive-aged women, is the presence of endometrial tissue outside of the uterine cavity. It is more common in women with pelvic pain or infertility (25 to 40 percent and 70 to 90 percent, respectively). Some women with endometriosis are asymptomatic, whereas others present with symptoms such as debilitating pelvic pain, dysmenorrhea, dyspareunia, and decreased fertility. Diagnosis of endometriosis in primary care is predominantly clinical. Initial treatment includes common agents used for primary dysmenorrhea, such as nonsteroidal anti-inflammatory drugs, combination estrogen/progestin contraceptives, or progestin-only contraceptives. There is some evidence that these agents are helpful and have few adverse effects. Referral to a gynecologist is necessary if symptoms persist or the patient is unable to become pregnant. Laparoscopy is commonly used to confirm the diagnosis before additional treatments are pursued. Further treatments include gonadotropin-releasing hormone analogues, danazol, or surgical removal of ectopic endometrial tissue. These interventions may control symptoms more effectively than initial treatments, but they can have significant adverse effects and limits on duration of therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23317074

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  19 in total

1.  Learning endometriosis phenotypes from patient-generated data.

Authors:  Iñigo Urteaga; Mollie McKillop; Noémie Elhadad
Journal:  NPJ Digit Med       Date:  2020-06-24

2.  MiR-182 inhibits proliferation, migration, invasion and inflammation of endometrial stromal cells through deactivation of NF-κB signaling pathway in endometriosis.

Authors:  Min Wu; Yi Zhang
Journal:  Mol Cell Biochem       Date:  2021-01-05       Impact factor: 3.396

3.  Severe teenage acne and risk of endometriosis.

Authors:  Jing Xie; Marina Kvaskoff; Yunhui Li; Mingfeng Zhang; Abrar A Qureshi; Stacey A Missmer; Jiali Han
Journal:  Hum Reprod       Date:  2014-08-19       Impact factor: 6.918

4.  Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis.

Authors:  Anu Manchikanti Gomez; Stephanie Arteaga; Natalie Ingraham; Jennet Arcara
Journal:  Contraception       Date:  2019-04-10       Impact factor: 3.375

5.  Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis.

Authors:  Emine Cosar; Ramanaiah Mamillapalli; Irene Moridi; Antoni Duleba; Hugh S Taylor
Journal:  Reprod Sci       Date:  2018-03-27       Impact factor: 3.060

6.  Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients with endometriosis in vitro.

Authors:  Fengying Huang; Huanping Wang; Ying Zou; Qiuhong Liu; Jing Cao; Tuanfang Yin
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

7.  A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.

Authors:  Akiko Kanto; Yasushi Kotani; Kosuke Murakami; Chiho Miyagawa; Hidekatsu Nakai; Noriomi Matsumura
Journal:  BMC Womens Health       Date:  2021-03-21       Impact factor: 2.809

8.  Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program.

Authors:  Thomas Strowitzki; Thomas Faustmann; Christoph Gerlinger; Ulrike Schumacher; Christiane Ahlers; Christian Seitz
Journal:  Int J Womens Health       Date:  2015-04-15

9.  Association between endometriosis and hyperprolactinemia in infertile women.

Authors:  Seddigheh Esmaeilzadeh; Parvaneh Mirabi; Zahra Basirat; Mahtab Zeinalzadeh; Soraya Khafri
Journal:  Iran J Reprod Med       Date:  2015-03

Review 10.  Clinical diagnosis of pelvic endometriosis: a scoping review.

Authors:  Hedyeh Riazi; Najmeh Tehranian; Saeideh Ziaei; Easa Mohammadi; Ebrahim Hajizadeh; Ali Montazeri
Journal:  BMC Womens Health       Date:  2015-05-08       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.